To determine the regulatory effects of β2M silencing between ER+ and ER− breast cancer cell lines with HER2−, the β2M gene was silenced, and possible relevant signaling molecules were analyzed by real-time PCR and western blotting. The gene discussed is ERBB2; the disease is breast cancer.